BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 8, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Appointments and advancements for June 28, 2023

June 28, 2023
New hires and promotions in the biopharma industry, including: Appia, Chimerix, Evommune, Ibio, Inflarx, Kineta, Ovid.
Read More

Regulatory actions for June 20-26, 2023

June 27, 2023
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Iaso, Jadeite, Lianbio, Moderna, Sirnaomics.
Read More

Other news to note for June 27, 2023

June 27, 2023
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Advancell Isotopes, Aslan, Astellas, CSL, Iveric, Point, Sumitomo, Uniqure, Zenyaku Kogyo.
Read More

In the clinic for June 20-26, 2023

June 27, 2023
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Aslan, Biocity, Curocell, Horizon, Invivyd, Minghui, Sumitomo, Takeda, Telix.
Read More

Regulatory actions for June 27, 2023

June 27, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Invo Bioscience, Roche.
Read More

Other news to note for June 27, 2023

June 27, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biodesix, Biosig, Cardinal Health, Cranius, Northstar Medical Radioisotopes, Nucleus Radiopharma, Owlet, Reified Labs, Thirona, Tivic.
Read More

In the clinic for June 27, 2023

June 27, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Senseonics, Vida Health.
Read More

Financings for June 27, 2023

June 27, 2023
Med-tech firms raising money in public or private financings, including: Augmedics, Flywheel, Microbot Medical, Pacific Biosciences, Presidio Medical.
Read More

Appointments and advancements for June 27, 2023

June 27, 2023
New hires and promotions in the med-tech industry, including: Boston Scientific, Dexcare, Koru Medical, Sequana Medical, Spectral Medical.
Read More

Regulatory actions for June 27, 2023

June 27, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alx, Invivyd, Pharvaris.
Read More
Previous 1 2 … 752 753 754 755 756 757 758 759 760 … 1792 1793 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing